BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Acetaminophen
,
rs2300478
,
GATA1
,
Coagulation
,
Leukemia
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pro-apoptotic protein
Summary
General Info
Curated Studies
Most Correlated Studies
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
HuH7 hepatic cells expressing hepatitis E virus ORF2
Embryonic fibroblasts with RICTOR knockout treated with IFNa
CML K-562 cells overexpressing wildtype or mutant CALR and treated with melittin
Foreskin fibroblast BJ cells IFN-β, IFN-γ treatment or mutant STAT1 overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration.
Model systems for rapid and slow induction of apoptosis obtained by inducible expression of pro-apop…
Time course changes of anti- and pro-apoptotic proteins in apigenin-induced genotoxicity.
The pro-apoptotic protein Bim is a microRNA target in kidney progenitors.
HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gene Expression Profiles in Patients With Permanent Atrial Fibrillation (AF) Versus Sinus Rhythm (SR…
HGS-ETR2 to Treat Children With Solid Tumors
A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer
A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ